PXD069713 is an
original dataset announced via ProteomeXchange.
Dataset Summary
| Title | Characterization of novel Contilisant+Tubastatin A Multi-Target Small Molecules with against glioblastoma |
| Description | Glioblastoma is the most common and aggressive primary brain tumor in adults, with patient prognosis remaining poor. Treatment resistance and tumor recurrence are frequent, primarily due to the high intra- and inter-tumoral heterogeneity and the presence of glioma stem cells. Thus, there is an urgent need for novel and more effective therapeutic strategies. Multitarget small molecules (MSMs) are emerging as a novel therapeutic strategy for the treatment of complex diseases such as cancer. In the present work, we have generated a novel family of indole-based MSMs with pharmacophoric moieties combining the parent compounds Contilisant and HDAC inhibitor Tubastatin A. Thus, the MSMs were designed to inhibit monoamine oxidases (MAOs), cholinesterases (ChEs) and histone deacetylases (HDACs), while acting as histamine H3 receptor (H3R) antagonists and sigma 1 receptor (S1R) agonists. We generated 4 different molecules and we focused on evaluating the activity of the 2 most efficient MSM compounds against glioblastoma, both in vitro and in vivo. In silico analyses indicated that these compounds are theoretically capable of crossing the blood–brain barrier, while exhibiting low toxicity in healthy cells. OMICs-based analyses further revealed that the compounds induce dysregulation of the cell cycle and alter neurotransmission-related activity in glioma stem cells. In conclusion, our findings demonstrate the potential antitumor activity of these compounds in preclinical models of glioblastoma. |
| HostingRepository | PRIDE |
| AnnounceDate | 2026-01-05 |
| AnnouncementXML | Submission_2026-01-04_17:01:55.002.xml |
| DigitalObjectIdentifier | |
| ReviewLevel | Peer-reviewed dataset |
| DatasetOrigin | Original dataset |
| RepositorySupport | Unsupported dataset by repository |
| PrimarySubmitter | Mikel Azkargorta |
| SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: NEWT:9606; |
| ModificationList | No PTMs are included in the dataset |
| Instrument | timsTOF Pro |
Dataset History
| Revision | Datetime | Status | ChangeLog Entry |
| 0 | 2025-10-21 01:24:48 | ID requested | |
| ⏵ 1 | 2026-01-04 17:01:56 | announced | |
Publication List
| 10.3390/pharmaceutics17121594; |
| de Go, ñ, i I, Artetxe-Zurutuza A, Elizazu J, Garcia-Garcia de Garayo R, Vergara-Arce J, Azkargorta M, Toledano-Pinedo M, Porro-P, é, rez A, Elortza F, Marco-Contelles JL, Sampron N, Iturrioz-Rodriguez N, Matheu A, Generation and Characterization of Novel Contilisant+Tubastatin a Multitarget Small Molecules Against Glioblastoma. Pharmaceutics, 17(12):(2025) [pubmed] |
Keyword List
| submitter keyword: Glioblastoma, MSM, glioma stem cells, proliferation, HDAC inhibition |
Contact List
| Felix Elortza |
| contact affiliation | CIC bioGUNE Proteomics Platform Bizkaia Tech. Park Build 800 Derio 48160 Spain |
| contact email | felortza@cicbiogune.es |
| lab head | |
| Mikel Azkargorta |
| contact affiliation | Proteomics Platform CIC bioGUNE |
| contact email | mazkargorta@cicbiogune.es |
| dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2026/01/PXD069713 |
| PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD069713
- Label: PRIDE project
- Name: Characterization of novel Contilisant+Tubastatin A Multi-Target Small Molecules with against glioblastoma